Porta, M <br/><br/>
Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials.  [electronic resource] 

 -  Diabetologia  Jun 2011 
 - 1298-303 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0428 
<br/><br/><label>Standard No.: </label>10.1007/s00125-010-2040-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abnormalities, Drug-Induced--epidemiology<br/>Adolescent<br/>Adult<br/>Angiotensin Receptor Antagonists--adverse effects<br/>Benzimidazoles--adverse effects<br/>Biphenyl Compounds<br/>Diabetes Mellitus, Type 1--complications<br/>Diabetic Retinopathy--drug therapy<br/>Female<br/>Humans<br/>Hypertension--drug therapy<br/>Pregnancy<br/>Pregnancy Complications, Cardiovascular--drug therapy<br/>Pregnancy Outcome<br/>Pregnancy Trimester, First<br/>Risk Factors<br/>Tetrazoles--adverse effects<br/>Young Adult